Clinical trial
Post Marketing Surveillance Study for ADYNOVATE in South Korea
NCT03824522 is registered in ClinicalTrials.gov with Takeda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post Marketing Surveillance Study for ADYNOVATE in South Korea
- Lead sponsor
- Takeda
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 25, 2019
- Completion date
- January 5, 2024
- Enrollment
- 341 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.